Roche Ramps Up Cancer Portfolio With $1.7bn Ignyta Buy

 
• By Kevin Grogan
Santa cap
Nice present: Ignyta is being acquired by Roche for $1.7bn • Source: Shutterstock

More from Deals

More from Business